Teva Pharmaceutical Industries (TEVA) Leases (2018 - 2025)
Historic Leases for Teva Pharmaceutical Industries (TEVA) over the last 11 years, with Q4 2025 value amounting to $345.0 million.
- Teva Pharmaceutical Industries' Leases fell 599.46% to $345.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $345.0 million, marking a year-over-year decrease of 599.46%. This contributed to the annual value of $345.0 million for FY2025, which is 599.46% down from last year.
- Teva Pharmaceutical Industries' Leases amounted to $345.0 million in Q4 2025, which was down 599.46% from $342.0 million recorded in Q3 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Leases ranged from a high of $531.0 million in Q2 2021 and a low of $342.0 million during Q3 2025
- Its 5-year average for Leases is $415.5 million, with a median of $412.0 million in 2023.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Leases skyrocketed by 58513.51% in 2021 and then plummeted by 1694.92% in 2022.
- Teva Pharmaceutical Industries' Leases (Quarter) stood at $495.0 million in 2021, then dropped by 15.35% to $419.0 million in 2022, then decreased by 5.25% to $397.0 million in 2023, then fell by 7.56% to $367.0 million in 2024, then decreased by 5.99% to $345.0 million in 2025.
- Its Leases was $345.0 million in Q4 2025, compared to $342.0 million in Q3 2025 and $358.0 million in Q2 2025.